SAN DIEGO, CA – March 1, 2022 – Mindera Health™, developers of the ground-breaking Dermal Intelligence™ platform that is the first realization of personalized medicine in psoriasis, has appointed Deborah L. Rice-Johnson to its Board of Directors, effective February 28, 2022. Ms. Rice-Johnson has more than 30 years of experience in the health insurance industry. Her leadership has redefined the payer-provider relationship and yielded unparalleled financial performance, as well as delivered innovative clinical solutions that aim to improve health outcomes.
“Deborah’s experience strengthens our commitment to support improved treatment outcomes for psoriasis patients and reduce healthcare system costs of expensive biologics in the US,” commented George Mahaffey, President and CEO of Mindera Health. “Her expertise and industry knowledge adds significant…